Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Marconi

Showing results (221-230 of 393) with videos related to

Pageof 40
Sort By:
The Journal of Infectious Diseases|May 13, 2009
Responsiveness of T cells to interleukin-7 is associated with higher CD4+ T cell counts in HIV-1-positive individuals with highly active antiretroviral therapy-induced viral load suppressionJose F Camargo, Hemant Kulkarni, Brian K Agan, et al.
Plos One|June 1, 2011
Cumulative viral load and virologic decay patterns after antiretroviral therapy in HIV-infected subjects influence CD4 recovery and AIDSVincent C Marconi, Greg Grandits, Jason F Okulicz, et al.
Clinical Epigenetics|December 15, 2018
Machine learning selected smoking-associated DNA methylation signatures that predict HIV prognosis and mortalityXinyu Zhang, Ying Hu, Bradley E Aouizerat, et al.
BMC Infectious Diseases|November 12, 2020
A packaged intervention to improve viral load monitoring within a deeply rural health district of South AfricaJ Brijkumar, B A Johnson, Y Zhao, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2008
Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South AfricaVincent C Marconi, Henry Sunpath, Zhigang Lu, et al.
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|April 5, 2024
Nationwide Genomic Surveillance and Response to COVID-19: The VA SeqFORCE and SeqCURE ConsortiumsJay Krishnan, Christopher W Woods, Mark Holodniy, et al.
Implementation Science Communications|August 1, 2024
Understanding barriers and facilitators to integrated HIV and hypertension care in South AfricaLeslie C M Johnson, Suha H Khan, Mohammed K Ali, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 17, 2009
Virologic response differences between African Americans and European Americans initiating highly active antiretroviral therapy with equal access to careAmy C Weintrob, Greg A Grandits, Brian K Agan, et al.
AIDS Research and Therapy|January 20, 2011
Long-term CD4+ lymphocyte response following HAART initiation in a U.S. Military prospective cohortAlan R Lifson, Elizabeth M Krantz, Lynn E Eberly, et al.
The Lancet. Respiratory Medicine|February 6, 2022
Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation: an exploratory, randomised, placebo-controlled trialE Wesley Ely, Athimalaipet V Ramanan, Cynthia E Kartman, et al.
Pageof 40

Showing results (221-230 of 393) with videos related to

Sort By:
Pageof 40
The Journal of Infectious Diseases|May 13, 2009
Responsiveness of T cells to interleukin-7 is associated with higher CD4+ T cell counts in HIV-1-positive individuals with highly active antiretroviral therapy-induced viral load suppressionJose F Camargo, Hemant Kulkarni, Brian K Agan, et al.
Plos One|June 1, 2011
Cumulative viral load and virologic decay patterns after antiretroviral therapy in HIV-infected subjects influence CD4 recovery and AIDSVincent C Marconi, Greg Grandits, Jason F Okulicz, et al.
Clinical Epigenetics|December 15, 2018
Machine learning selected smoking-associated DNA methylation signatures that predict HIV prognosis and mortalityXinyu Zhang, Ying Hu, Bradley E Aouizerat, et al.
BMC Infectious Diseases|November 12, 2020
A packaged intervention to improve viral load monitoring within a deeply rural health district of South AfricaJ Brijkumar, B A Johnson, Y Zhao, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2008
Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South AfricaVincent C Marconi, Henry Sunpath, Zhigang Lu, et al.
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|April 5, 2024
Nationwide Genomic Surveillance and Response to COVID-19: The VA SeqFORCE and SeqCURE ConsortiumsJay Krishnan, Christopher W Woods, Mark Holodniy, et al.
Implementation Science Communications|August 1, 2024
Understanding barriers and facilitators to integrated HIV and hypertension care in South AfricaLeslie C M Johnson, Suha H Khan, Mohammed K Ali, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 17, 2009
Virologic response differences between African Americans and European Americans initiating highly active antiretroviral therapy with equal access to careAmy C Weintrob, Greg A Grandits, Brian K Agan, et al.
AIDS Research and Therapy|January 20, 2011
Long-term CD4+ lymphocyte response following HAART initiation in a U.S. Military prospective cohortAlan R Lifson, Elizabeth M Krantz, Lynn E Eberly, et al.
The Lancet. Respiratory Medicine|February 6, 2022
Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation: an exploratory, randomised, placebo-controlled trialE Wesley Ely, Athimalaipet V Ramanan, Cynthia E Kartman, et al.
Pageof 40